Literature DB >> 17435588

Cryptococcosis and idiopathic CD4 lymphocytopenia.

Dimitrios I Zonios1, Judith Falloon, Chiung-Yu Huang, Doreen Chaitt, John E Bennett.   

Abstract

We reviewed the cases of 11 patients with cryptococcosis and idiopathic CD4 lymphocytopenia (ICL) referred to our institution in the previous 12 years, as well as 42 similar cases reported in the literature, to assess the characteristics of the infection in this population. Cryptococcosis in 53 patients with ICL had features in common with cryptococcosis in previously normal patients. ICL patients had a slight male predominance (1.2:1) and a median age of presentation of 41 years (range, 4.5-85 yr). Initial cerebrospinal fluid findings showed glucose below 40 mg/dL in 60% of the patients, a median pleocytosis of 59 white blood cells/mm (range, 0-884), and protein of 156 mg/dL (range, 25-402 mg/dL). The median CD4 count at diagnosis of ICL and at the last available measurement was 82 (range, 7-292) and 132 (range, 13-892) cells/mm, respectively, for an average follow-up of 32 months in 46 patients. Unlike previously normal patients with cryptococcosis, those with ICL had an excess incidence of dermatomal zoster (7 episodes in 46 ICL cases). Pneumocystis pneumonia was rare (1 case), casting doubt on the need for prophylaxis in patients with ICL. A favorable outcome (cured or improved) may be more common in ICL patients than in previously normal patients with cryptococcal meningitis and no predisposing factors. Identification of ICL in patients who were apparently normal before the onset of cryptococcosis appears to be useful because it predicts a favorable outcome. Patients with cryptococcal infection and ICL have an increased likelihood of developing dermatomal zoster. The long-term follow-up of these patients offers some reassurance regarding favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435588     DOI: 10.1097/md.0b013e31803b52f5

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  43 in total

1.  Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects.

Authors:  Anil A Panackal; Lindsey B Rosen; Gulbu Uzel; Michael J Davis; Guowu Hu; Adebowale Adeyemo; Fasil Tekola-Ayele; Andrea Lisco; Christopher Diachok; Jonathan D Kim; Dawn Shaw; Irini Sereti; Jennifer Stoddard; Julie Niemela; Sergio D Rosenzweig; John E Bennett; Peter R Williamson
Journal:  Open Forum Infect Dis       Date:  2017-06-07       Impact factor: 3.835

2.  Idiopathic CD4 lymphocytopenia: Pathogenesis, etiologies, clinical presentations and treatment strategies.

Authors:  Hale Yarmohammadi; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2017-10       Impact factor: 6.347

3.  Genetic Susceptibility to Fungal Infections in Humans.

Authors:  Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2011-12-15

4.  Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.

Authors:  N Oliver; T Luong; A Tchakarov; M Abdelrahim; V E Mulanovich; D P Kontoyiannis; R Jones; P Kebriaei; J Samuels; W Glass; A Abudayyeh
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

5.  Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx.

Authors:  Hyun Ah Yoon; Uriel Felsen; Tao Wang; Liise-Anne Pirofski
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

Review 6.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 7.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

8.  Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.

Authors:  Dimitrios I Zonios; Judith Falloon; John E Bennett; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen B Kovacs; Stephen J Kovacs; Joseph A Kovacs; Richard T Davey; H Clifford Lane; Henry Masur; Irini Sereti
Journal:  Blood       Date:  2008-05-02       Impact factor: 22.113

9.  Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.

Authors:  Vladimír Buchta; Petr Prášil; Marcela Vejsová; Roman Mottl; Radka Kutová; Marcela Drahošová; Stanislav Plíšek
Journal:  Folia Microbiol (Praha)       Date:  2014-06-20       Impact factor: 2.099

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.